What Is Carlos Carrasco Illness?

Frank Jones

Updated on:

What Is Carlos Carrasco Illness

Carlos Carrasco is a professional baseball player for the New York Mets, but his journey to the major leagues has not been without challenges. In 2019, Carrasco was diagnosed with chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow.

Despite this setback, Carrasco remained determined to beat the illness and return to the sport he loves.

In this blog post, we will explore what CML is, how Carrasco was diagnosed, the treatment he received, and his inspiring return to baseball.

Carrasco’s story serves as a reminder that even in the face of adversity, with hard work and perseverance, one can overcome seemingly insurmountable obstacles.

What is Chronic Myeloid Leukemia?

Chronic myeloid leukemia (CML) is a type of cancer that affects the blood and bone marrow. It is characterized by an overproduction of immature white blood cells called myeloid cells, which accumulate in the bone marrow and interfere with the production of other blood cells.

As a result, individuals with CML often experience a shortage of red blood cells, platelets, and mature white blood cells, which can cause a variety of symptoms.

Some common symptoms of CML include fatigue, weakness, fever, night sweats, weight loss, and easy bruising or bleeding.

In some cases, individuals with CML may also experience abdominal pain or fullness, swollen lymph nodes, or a feeling of fullness in the upper left side of the abdomen.

CML is considered a type of cancer because the abnormal white blood cells grow and divide uncontrollably, leading to the formation of a mass of cells called a tumor. Over time, these cells can spread to other parts of the body and interfere with normal organ function.

While CML is a serious illness, it is treatable with medication and other therapies, and many individuals with the condition are able to live long and healthy lives.

Carlos Carrasco’s Diagnosis

Carlos Carrasco was diagnosed with chronic myeloid leukemia (CML) in June 2019. The diagnosis came after several weeks of testing, which began after Carrasco reported feeling persistent fatigue and other symptoms.

Carrasco had previously been in good health and had no history of cancer in his family, so the diagnosis came as a shock to him and his loved ones.

The diagnosis of CML is typically made through a combination of blood tests and bone marrow biopsy. Blood tests can reveal abnormal levels of white blood cells and other markers that suggest CML, while a bone marrow biopsy involves taking a sample of bone marrow tissue to examine under a microscope for the presence of cancerous cells.

Upon receiving the diagnosis, Carrasco was understandably devastated, but he remained determined to fight the disease and return to baseball.

In an interview with ESPN, Carrasco said, “I was crying a lot, but I said, ‘I need to do this. I need to fight, because I want to be here for a long time with my family, with my teammates, with baseball.'”

Carrasco’s positive attitude and resilience in the face of such a difficult diagnosis inspired many, and he received an outpouring of support from fans, teammates, and fellow athletes.

Carrasco’s Treatment

After being diagnosed with chronic myeloid leukemia (CML), Carlos Carrasco underwent treatment that included chemotherapy and a targeted therapy medication called imatinib.

Imatinib works by blocking the action of a protein called BCR-ABL, which is produced by cancerous cells in CML. This medication is typically taken daily in pill form, and it can help to control the growth and spread of cancerous cells.

Carrasco’s treatment lasted for several months, during which time he was unable to play baseball due to the side effects of chemotherapy and the need to focus on his health.

However, he remained in contact with his teammates and coaches, and he continued to train and work towards his goal of returning to the field.

Carrasco’s treatment was successful in putting his cancer into remission, and he was able to return to baseball in 2020.

While he experienced some setbacks due to the COVID-19 pandemic and a subsequent hamstring injury, Carrasco was able to make a strong comeback and finish the season with a 2-3 record and a 3.38 ERA.

It’s worth noting that while imatinib and other targeted therapy medications can be effective in treating CML, they can also have side effects such as fatigue, nausea, and muscle cramps.

In addition, individuals with CML may need to continue taking medication for many years in order to keep the cancer in remission. However, with proper treatment and management, many people with CML are able to lead normal, healthy lives.

Carrasco’s Return to Baseball

Carlos Carrasco made his return to baseball in 2020, after undergoing treatment for chronic myeloid leukemia (CML). He started the season on the injured list due to a hamstring injury, but he was able to make his season debut in September.

Carrasco’s return to the field was met with excitement and support from fans and teammates alike. He pitched in four games during the regular season, finishing with a 2-1 record and a 3.12 ERA. He also appeared in one game during the playoffs, allowing one run in two innings pitched.

In addition to his success on the field, Carrasco was admired for his ability to balance his treatment for CML with his responsibilities as a professional athlete.

He continued to take his medication and attend regular check-ups with his doctors while also focusing on his training and performance.

In an interview with MLB.com, Carrasco spoke about the importance of maintaining a positive mindset during his treatment and recovery.

“The mind is a powerful thing,” he said. “I just tried to stay positive, always thinking about good things, thinking about my family, thinking about being back with my teammates and back on the field.”

Carrasco’s return to baseball was an inspiring example of perseverance and determination in the face of adversity. He continues to play for the New York Mets and serve as an inspiration to others who are fighting cancer or other challenges in their lives.

Chronic Myeloid Leukemia (CML) at a Glance

DefinitionA type of cancer that affects the blood and bone marrow, causing the body to produce too many white blood cells
SymptomsFatigue, weakness, fever, night sweats, unexplained weight loss, abdominal pain or fullness, enlarged spleen
DiagnosisPhysical exam, blood tests, bone marrow biopsy, genetic testing
TreatmentChemotherapy, radiation therapy, targeted therapy, bone marrow transplant
PrognosisWith proper treatment, many people with CML are able to achieve remission and manage their symptoms effectively
StatisticsCML accounts for approximately 10-15% of all cases of leukemia in adults. It is more commonly diagnosed in men than in women, and it typically affects individuals over the age of 60.

This table provides a quick overview of some of the key aspects of chronic myeloid leukemia, including its definition, symptoms, diagnosis, treatment options, prognosis, and some statistics about the disease.

Frequently Asked Questions

Can chronic myeloid leukemia be cured?

There is currently no known cure for chronic myeloid leukemia. However, with proper treatment, many people with CML are able to achieve remission and manage their symptoms effectively.

What are the long-term effects of imatinib?

Imatinib is generally well-tolerated, but it can have some long-term side effects. These can include fatigue, muscle cramps, skin rash, and nausea. Additionally, some studies have suggested that long-term use of imatinib may increase the risk of cardiovascular disease.

How common is chronic myeloid leukemia?

CML is a relatively rare form of leukemia, accounting for approximately 10-15% of all cases of leukemia in adults. It is more commonly diagnosed in men than in women, and it typically affects individuals over the age of 60.

Can CML be prevented?

There is no known way to prevent chronic myeloid leukemia, as the exact cause of the disease is not yet fully understood. However, maintaining a healthy lifestyle and avoiding exposure to certain chemicals and toxins may help to reduce the risk of developing leukemia and other types of cancer.

How is CML diagnosed?

CML is typically diagnosed through a combination of physical exams, blood tests, and bone marrow biopsies. Doctors may look for abnormalities in the number or structure of certain blood cells, as well as the presence of genetic mutations associated with CML.

To Recap

Carlos Carrasco’s journey with chronic myeloid leukemia (CML) is a powerful example of the resilience and determination that is possible in the face of a difficult diagnosis.

Despite his initial shock and sadness, Carrasco was able to maintain a positive attitude and focus on his recovery, both as a patient and as a professional athlete.

Through his treatment for CML and his return to baseball, Carrasco has inspired countless individuals with his courage, strength, and dedication. His story is a reminder of the importance of remaining hopeful and optimistic, even in the face of difficult challenges.

While CML can be a serious and life-altering diagnosis, with proper treatment and management, many individuals are able to achieve remission and lead healthy, fulfilling lives

Carrasco’s journey is a testament to the power of medicine, science, and the human spirit to overcome adversity and achieve great things.

Leave a Comment